An Exploratory study on safety and tolerability of hydration using oral rehydration solution during cisplatin chemotherapy
- Conditions
- ung cancer patients planned to receive two or more cycles of cisplatin chemotherapy
- Registration Number
- JPRN-UMIN000007887
- Lead Sponsor
- Department of Respiratory Medicine Kyorin Univercity Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Not provided
1. Patients with the serum creatinine level exceeding the upper limit of the hospital or with the estimated Ccr of 60mL/min or lower 2. Patients with intractable ascites or pleural effusion except those who have been treated by pleurodesis. 3. Patients with psychiatric disease or psychological symptom 4. Female patients of childbearing potential, pregnancy, or lactation 5. Patients with poorly controlled diabetes 6. Patients who meet the criteria specified in "contraindication" or "careful administration" in the package inserts of the intravenous solutions used in the study 7. Patients with difficulty eating or with grade 2 or higher anorexia (CTCAE 4.0) 8. Patients otherwise deemed unsuitable for inclusion in the study for any other reason based on the assessment by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method